Your browser doesn't support javascript.
Remdesivir modifies interferon response in hospitalized COVID-19 patients.
Murphy, Sarah L; Halvorsen, Bente; Barratt-Due, Andreas; Dyrhol-Riise, Anne Ma; Aukrust, Pål; Trøseid, Marius; Dahl, Tuva B.
  • Murphy SL; Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.
  • Halvorsen B; Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway.
  • Barratt-Due A; Division of Critical Care and Emergencies, Oslo University Hospital, Oslo, Norway; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Dyrhol-Riise AM; Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Aukrust P; Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Trøseid M; Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, University of Oslo, Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Dahl TB; Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Division of Critical Care and Emergencies, Oslo University Hospital, Oslo, Norway. Electronic address: t.b.dahl@medisin.uio.no.
J Infect ; 85(5): 573-607, 2022 11.
Article in English | MEDLINE | ID: covidwho-1966854
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article Affiliation country: J.jinf.2022.07.021

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article Affiliation country: J.jinf.2022.07.021